Concord Biotech Limited — Others, 29-05-2025: Change in Company Secretary/Compliance Officer

Concord Biotech Limited has announced a board meeting to approve the financial results for the quarter and half-year. The Board approved the audited standalone and consolidated results, with auditors giving an unmodified opinion. The company reported revenue from operations of Rs. 429.88 Cr and profit after tax of Rs. 372.96 Cr for the year. A dividend of Rs. 10.70 per share has been proposed, pending shareholder approval. Management updates include appointing Ms. Hina Patel as Company Secretary and Compliance Officer, along with new secretarial, internal, and cost auditors for FY 2025-26.